BBIO vs HRMY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 04, 2026

BBIO

41.1
AI Score
VS
HRMY Wins

HRMY

57.4
AI Score

Investment Advisor Scores

BBIO

41score
Recommendation
HOLD

HRMY

57score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric BBIO HRMY Winner
Revenue 791.36M 476.67M BBIO
Net Income -372.97M 107.92M HRMY
Net Margin -47.1% 22.6% HRMY
Operating Income -224.67M 126.61M HRMY
ROE 22.4% 10.8% BBIO
ROA -17.3% 7.9% HRMY
Total Assets 2.16B 1.37B BBIO
Cash 1.53B 549.77M BBIO
Debt/Equity -1.58 0.15 BBIO
Current Ratio 2.09 3.48 HRMY

Relative Price Performance (Last 90 Days)

BBIO 1M: +11.9% · 3M: -9.7% HRMY 1M: -7.3% · 3M: -3.2%

Current Technical Phase

BBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 65

RSI (14): 65.4 · Price: $74.03

HRMY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 42

RSI (14): 41.9 · Price: $37.02

Fundamentals Snapshot

Metric BBIO HRMY
Market Cap — —
Forward P/E -228.5 5.3
Trailing P/E — 12.2
Revenue (TTM) — —
Revenue Growth 1.9% 0.3%
Gross Margin 0.9% 0.8%
Operating Margin 0.0% 0.3%
EPS -3.03 3.10
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, HRMY is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.